4th Quarter - Termination
PARENT PROJECT MUSCULAR DYSTROPHY for PARENT PROJECT MUSCULAR DYSTROPHY
Income
—
Expenses
$20,000
Expense method
A: Lobbying Disclosure Act definitions
Terminated
Oct 31, 2019
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report | Jan 21, 2020 | $20,000 | Replaced |
| 4th Quarter - Termination (this page) | Apr 20, 2020 | $20,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
21st Century Cures/Biomedical Innovations; PDUFA VI; Appropriations Bill/Report Language, Orphan Drug Act Re-authorization, Newborn Screening Saves Lives Act Re-authorization
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNIE KENNEDY | — |
Defense DEF
Congressionally Directed Medical Research Programs
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNIE KENNEDY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.